32 results
10-K
2022 FY
EX-10.10
XBIT
XBiotech Inc
Annual report
15 Mar 23
4:58pm
10-K
2022 FY
EX-10.13
XBIT
XBiotech Inc
Annual report
15 Mar 23
4:58pm
10-K
2022 FY
EX-10.14
XBIT
XBiotech Inc
Annual report
15 Mar 23
4:58pm
10-K
2022 FY
EX-10.9
XBIT
XBiotech Inc
Annual report
15 Mar 23
4:58pm
10-K
2019 FY
EX-10.14
XBIT
XBiotech Inc
Annual report
16 Mar 20
5:24pm
8-K
EX-10.2
loy7s9yq60l5skx1 ufu
30 Dec 19
XBiotech Closes on Sale of True Human Antibody Bermekimab to Janssen
5:08pm
8-K
EX-10.3
tb9ba
30 Dec 19
XBiotech Closes on Sale of True Human Antibody Bermekimab to Janssen
5:08pm
8-K
EX-10.1
ong7jn533e qhq
30 Dec 19
XBiotech Closes on Sale of True Human Antibody Bermekimab to Janssen
5:08pm
8-K
EX-10.1
ungbe9
16 Jul 19
XBiotech Adds Dr. Peter Libby, Renowned Cardiologist and Research Pioneer in Inflammation and Cardiovascular Disease, to its Corporate Board
12:36pm
8-K
EX-10.1
e0i h00d8lht42
1 May 19
Entry into a Material Definitive Agreement
5:20pm
8-K
EX-10.1
cast6r3o2zhn7
3 Mar 17
XBiotech Announces Registered Direct Offering of Common Shares
12:00am
8-K
EX-10.1
17cif4seq
26 Sep 16
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
1kme5zvym9t
3 May 16
Departure of Directors or Certain Officers
12:00am
8-K
EX-10.1
qqe6o4csev13j
11 Jun 15
Departure of Directors or Certain Officers
12:00am
S-1/A
EX-10.7
4jr6mmgfob
10 Mar 15
IPO registration (amended)
12:00am
S-1/A
EX-10.9
qmjjc3yqrcfh2 h3
10 Mar 15
IPO registration (amended)
12:00am
S-1/A
EX-10.6
b2b ap0202qwc4
10 Mar 15
IPO registration (amended)
12:00am
S-1/A
EX-10.10
21vaxpg d9vs1
10 Mar 15
IPO registration (amended)
12:00am
S-1/A
EX-10.11
i7193bo2z013o guh4
10 Mar 15
IPO registration (amended)
12:00am